Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
Tubulin polymerization promoter
DRUG CLASS:
Tubulin polymerization promoter
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
carboplatin (208)
paclitaxel (178)
docetaxel (163)
TH 1902 (8)
docetaxel nanoformulation (0)
docetaxel polymeric micelle (0)
CPO100 (0)
LE-DT (0)
ModraDoc006/r (0)
STK-01 (0)
BAY86-5302 (0)
UTD1 (0)
carboplatin (208)
paclitaxel (178)
docetaxel (163)
TH 1902 (8)
docetaxel nanoformulation (0)
docetaxel polymeric micelle (0)
CPO100 (0)
LE-DT (0)
ModraDoc006/r (0)
STK-01 (0)
BAY86-5302 (0)
UTD1 (0)
›
Associations
(474)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Squamous Cell Carcinoma of Head and Neck
No biomarker
Squamous Cell Carcinoma of Head and Neck
cisplatin + docetaxel + 5-fluorouracil
Sensitive: A1 - Approval
cisplatin + docetaxel + 5-fluorouracil
Sensitive
:
A1
cisplatin + docetaxel + 5-fluorouracil
Sensitive: A1 - Approval
cisplatin + docetaxel + 5-fluorouracil
Sensitive
:
A1
No biomarker
Gastric Adenocarcinoma
No biomarker
Gastric Adenocarcinoma
cisplatin + docetaxel + 5-fluorouracil
Sensitive: A1 - Approval
cisplatin + docetaxel + 5-fluorouracil
Sensitive
:
A1
cisplatin + docetaxel + 5-fluorouracil
Sensitive: A1 - Approval
cisplatin + docetaxel + 5-fluorouracil
Sensitive
:
A1
No biomarker
Gastroesophageal Junction Adenocarcinoma
No biomarker
Gastroesophageal Junction Adenocarcinoma
cisplatin + docetaxel + 5-fluorouracil
Sensitive: A1 - Approval
cisplatin + docetaxel + 5-fluorouracil
Sensitive
:
A1
cisplatin + docetaxel + 5-fluorouracil
Sensitive: A1 - Approval
cisplatin + docetaxel + 5-fluorouracil
Sensitive
:
A1
No biomarker
Breast Cancer
No biomarker
Breast Cancer
docetaxel + doxorubicin hydrochloride + cyclophosphamide
Sensitive: A1 - Approval
docetaxel + doxorubicin hydrochloride + cyclophosphamide
Sensitive
:
A1
docetaxel + doxorubicin hydrochloride + cyclophosphamide
Sensitive: A1 - Approval
docetaxel + doxorubicin hydrochloride + cyclophosphamide
Sensitive
:
A1
No biomarker
Peritoneal Cancer
No biomarker
Peritoneal Cancer
carboplatin + micellar paclitaxel
Sensitive: A1 - Approval
carboplatin + micellar paclitaxel
Sensitive
:
A1
carboplatin + micellar paclitaxel
Sensitive: A1 - Approval
carboplatin + micellar paclitaxel
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
No biomarker
Fallopian Tube Cancer
carboplatin + micellar paclitaxel
Sensitive: A1 - Approval
carboplatin + micellar paclitaxel
Sensitive
:
A1
carboplatin + micellar paclitaxel
Sensitive: A1 - Approval
carboplatin + micellar paclitaxel
Sensitive
:
A1
No biomarker
Ovarian Cancer
No biomarker
Ovarian Cancer
carboplatin + micellar paclitaxel
Sensitive: A1 - Approval
carboplatin + micellar paclitaxel
Sensitive
:
A1
carboplatin + micellar paclitaxel
Sensitive: A1 - Approval
carboplatin + micellar paclitaxel
Sensitive
:
A1
No biomarker
Non Small Cell Lung Cancer
No biomarker
Non Small Cell Lung Cancer
carboplatin + albumin-bound paclitaxel
Sensitive: A1 - Approval
carboplatin + albumin-bound paclitaxel
Sensitive
:
A1
carboplatin + albumin-bound paclitaxel
Sensitive: A1 - Approval
carboplatin + albumin-bound paclitaxel
Sensitive
:
A1
No biomarker
Breast Cancer
No biomarker
Breast Cancer
docetaxel + doxorubicin hydrochloride
Sensitive: A1 - Approval
docetaxel + doxorubicin hydrochloride
Sensitive
:
A1
docetaxel + doxorubicin hydrochloride
Sensitive: A1 - Approval
docetaxel + doxorubicin hydrochloride
Sensitive
:
A1
No biomarker
Breast Cancer
No biomarker
Breast Cancer
docetaxel
Sensitive: A1 - Approval
docetaxel
Sensitive
:
A1
docetaxel
Sensitive: A1 - Approval
docetaxel
Sensitive
:
A1
No biomarker
Non Small Cell Lung Cancer
No biomarker
Non Small Cell Lung Cancer
docetaxel
Sensitive: A1 - Approval
docetaxel
Sensitive
:
A1
docetaxel
Sensitive: A1 - Approval
docetaxel
Sensitive
:
A1
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
docetaxel + prednisone
Sensitive: A1 - Approval
docetaxel + prednisone
Sensitive
:
A1
docetaxel + prednisone
Sensitive: A1 - Approval
docetaxel + prednisone
Sensitive
:
A1
No biomarker
Breast Cancer
No biomarker
Breast Cancer
docetaxel + capecitabine
Sensitive: A1 - Approval
docetaxel + capecitabine
Sensitive
:
A1
docetaxel + capecitabine
Sensitive: A1 - Approval
docetaxel + capecitabine
Sensitive
:
A1
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
docetaxel
Sensitive: A1 - Approval
docetaxel
Sensitive
:
A1
docetaxel
Sensitive: A1 - Approval
docetaxel
Sensitive
:
A1
No biomarker
Non Small Cell Lung Cancer
No biomarker
Non Small Cell Lung Cancer
cisplatin + docetaxel
Sensitive: A1 - Approval
cisplatin + docetaxel
Sensitive
:
A1
cisplatin + docetaxel
Sensitive: A1 - Approval
cisplatin + docetaxel
Sensitive
:
A1
No biomarker
Small Intestinal Carcinoma
No biomarker
Small Intestinal Carcinoma
gemcitabine + docetaxel
Sensitive: A2 - Guideline
gemcitabine + docetaxel
Sensitive
:
A2
gemcitabine + docetaxel
Sensitive: A2 - Guideline
gemcitabine + docetaxel
Sensitive
:
A2
No biomarker
Oral Cancer
No biomarker
Oral Cancer
cisplatin + paclitaxel + 5-fluorouracil
Sensitive: A2 - Guideline
cisplatin + paclitaxel + 5-fluorouracil
Sensitive
:
A2
cisplatin + paclitaxel + 5-fluorouracil
Sensitive: A2 - Guideline
cisplatin + paclitaxel + 5-fluorouracil
Sensitive
:
A2
No biomarker
Oral Cancer
No biomarker
Oral Cancer
paclitaxel
Sensitive: A2 - Guideline
paclitaxel
Sensitive
:
A2
paclitaxel
Sensitive: A2 - Guideline
paclitaxel
Sensitive
:
A2
No biomarker
Oral Cancer
No biomarker
Oral Cancer
docetaxel
Sensitive: A2 - Guideline
docetaxel
Sensitive
:
A2
docetaxel
Sensitive: A2 - Guideline
docetaxel
Sensitive
:
A2
No biomarker
Oral Cancer
No biomarker
Oral Cancer
cisplatin + docetaxel
Sensitive: A2 - Guideline
cisplatin + docetaxel
Sensitive
:
A2
cisplatin + docetaxel
Sensitive: A2 - Guideline
cisplatin + docetaxel
Sensitive
:
A2
No biomarker
Oral Cancer
No biomarker
Oral Cancer
carboplatin + paclitaxel
Sensitive: A2 - Guideline
carboplatin + paclitaxel
Sensitive
:
A2
carboplatin + paclitaxel
Sensitive: A2 - Guideline
carboplatin + paclitaxel
Sensitive
:
A2
No biomarker
Oral Cancer
No biomarker
Oral Cancer
cisplatin + docetaxel + 5-fluorouracil
Sensitive: A2 - Guideline
cisplatin + docetaxel + 5-fluorouracil
Sensitive
:
A2
cisplatin + docetaxel + 5-fluorouracil
Sensitive: A2 - Guideline
cisplatin + docetaxel + 5-fluorouracil
Sensitive
:
A2
No biomarker
Oral Cancer
No biomarker
Oral Cancer
cisplatin + paclitaxel
Sensitive: A2 - Guideline
cisplatin + paclitaxel
Sensitive
:
A2
cisplatin + paclitaxel
Sensitive: A2 - Guideline
cisplatin + paclitaxel
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
No biomarker
Oropharyngeal Cancer
cisplatin + paclitaxel
Sensitive: A2 - Guideline
cisplatin + paclitaxel
Sensitive
:
A2
cisplatin + paclitaxel
Sensitive: A2 - Guideline
cisplatin + paclitaxel
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
No biomarker
Oropharyngeal Cancer
docetaxel
Sensitive: A2 - Guideline
docetaxel
Sensitive
:
A2
docetaxel
Sensitive: A2 - Guideline
docetaxel
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
No biomarker
Oropharyngeal Cancer
paclitaxel
Sensitive: A2 - Guideline
paclitaxel
Sensitive
:
A2
paclitaxel
Sensitive: A2 - Guideline
paclitaxel
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
No biomarker
Oropharyngeal Cancer
carboplatin
Sensitive: A2 - Guideline
carboplatin
Sensitive
:
A2
carboplatin
Sensitive: A2 - Guideline
carboplatin
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
No biomarker
Oropharyngeal Cancer
carboplatin + paclitaxel
Sensitive: A2 - Guideline
carboplatin + paclitaxel
Sensitive
:
A2
carboplatin + paclitaxel
Sensitive: A2 - Guideline
carboplatin + paclitaxel
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
No biomarker
Oropharyngeal Cancer
cisplatin + docetaxel
Sensitive: A2 - Guideline
cisplatin + docetaxel
Sensitive
:
A2
cisplatin + docetaxel
Sensitive: A2 - Guideline
cisplatin + docetaxel
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
No biomarker
Oropharyngeal Cancer
cisplatin + paclitaxel + 5-fluorouracil
Sensitive: A2 - Guideline
cisplatin + paclitaxel + 5-fluorouracil
Sensitive
:
A2
cisplatin + paclitaxel + 5-fluorouracil
Sensitive: A2 - Guideline
cisplatin + paclitaxel + 5-fluorouracil
Sensitive
:
A2
No biomarker
Oral Cancer
No biomarker
Oral Cancer
carboplatin + 5-fluorouracil
Sensitive: A2 - Guideline
carboplatin + 5-fluorouracil
Sensitive
:
A2
carboplatin + 5-fluorouracil
Sensitive: A2 - Guideline
carboplatin + 5-fluorouracil
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
No biomarker
Oropharyngeal Cancer
carboplatin + 5-fluorouracil
Sensitive: A2 - Guideline
carboplatin + 5-fluorouracil
Sensitive
:
A2
carboplatin + 5-fluorouracil
Sensitive: A2 - Guideline
carboplatin + 5-fluorouracil
Sensitive
:
A2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login